arrow_back Back Filing freshness 10-Q FY 2014 SEC EDGAR

download Export Data

CTT PHARMACEUTICAL HOLDINGS, INC.

CTTH

— Price unavailable

17 Visible periods

16 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

CTT PHARMACEUTICAL HOLDINGS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -90.5% ↘

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$227.84K

↑ +106.3% —

FCF / Share Free cash flow per share

$-0.01

↑ +86.7% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 2 metrics

Metric	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗	FY 1999 Dec 31, 1999 10-K ↗	FY 1998 Dec 31, 1998 10-K ↗
Net Income Growth YoY (%)	106.3% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	86.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-207.9% Weak Weak Year-over-year change in free cash flow	82.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗	FY 1999 Dec 31, 1999 10-K ↗	FY 1998 Dec 31, 1998 10-K ↗
FCF / Net Income (x)	-0.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.08x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.53x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗	FY 1999 Dec 31, 1999 10-K ↗	FY 1998 Dec 31, 1998 10-K ↗
Return on Invested Capital (%)	-90.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-30.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	244.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-131.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	514.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-40.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1474.7% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-588.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-164.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	38.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+159%)	-45.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-403%)	259.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1631%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗	FY 1999 Dec 31, 1999 10-K ↗	FY 1998 Dec 31, 1998 10-K ↗
Net Debt (USD)	$-81.18K	$-823.00	$-12.09K	$-569.38K	$-46.19K	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗	FY 1999 Dec 31, 1999 10-K ↗	FY 1998 Dec 31, 1998 10-K ↗
Basic EPS, GAAP (USD)	—	$0.01	$-0.11	$0.42	$-0.13	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	$-0.01	$-0.11	$-0.04	$-0.20	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.00	$-0.03	$-0.04	$0.05	$-0.00	—	—	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.00	$-0.03	$-0.04	$0.05	$-0.00	—	—	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	—	9.41M	9.41M	8.92M	8.47M	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗	FY 1999 Dec 31, 1999 10-K ↗	FY 1998 Dec 31, 1998 10-K ↗
Working Capital (USD)	—	$-243.13K	$-386.33K	$-2.98M	$-425.05K	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$586.63K	$-243.13K	$-386.33K	$456.45K	$-317.89K	$-1.25M	$151.39K	$557.86K	$765.03K	$74.21K	$1.92M	$-1.71M	$-577.76K	$-17.61K	$-10.36K	$-83.44K	$-245.66K

📋 What is driving earnings? 2 metrics

Metric	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗	FY 1999 Dec 31, 1999 10-K ↗	FY 1998 Dec 31, 1998 10-K ↗
Net Income, GAAP (USD)	$227.84K	$110.46K	$-1.00M	$3.74M	$-1.10M	—	—	—	—	—	—	—	—	—	—	—	—
Operating Cash Flow (USD)	$-72.25K	$-136.23K	$-1.03M	$-316.13K	$-1.67M	—	—	—	—	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 34 quarters

CTT PHARMACEUTICAL HOLDINGS, INC.

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CTTH with peers